Skip to main content

Bill Ackman, founder and CEO of hedge fund Pershing Square Capital Management, speaks to the audience about Herbalife company in New York, July 22, 2014.

Eduardo Munoz/Reuters

Pershing Square Holdings Ltd., one of the funds managed by activist investor Bill Ackman, plans to raise about $2-billion from an initial public offering in Amsterdam.

The company will have a market capitalization of at least $5-billion after it lists on the Euronext Amsterdam, Pershing Square Holdings said in a statement today. Thirty so-called cornerstone investors have already committed funds worth $1.5-billion to the sale, and the shares are being priced at $25 apiece, the statement said.

Ackman, who is waging campaigns against management at Herbalife Ltd. and Allergan Inc., has wanted to raise capital since at least 2011 to avoid a repeat of the financial crisis, when investors withdrew about 27 per cent of the New York-based firm's funds.

Story continues below advertisement

Pershing Square Holdings was started in December 2012 to invest alongside other funds managed by Ackman's Pershing Square Capital Management LP. More than 300 investors have money in the fund, which had a net asset value of approximately $2.9-billion as of June 30. The parent company, which is not itself going public, and its management will invest $100-million at or around the time of the IPO.

"Because we are an active, control and influence-oriented investor, we have avoided being fully invested because of the risk of investor redemptions," Ackman wrote in an investor letter obtained by Bloomberg News in August. The IPO of the fund will address that as it "will increase the amount of our capital that is permanent," he wrote in the letter.

Report an error
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies